Diagnostics

Alzheimer’s disease genetic testing & genoSCORE™-LAB 3:54
Alzheimer’s disease genetic testing & genoSCORE™-LAB
Richard Pither • 21 Sep 2021
Diagnosing parkinsonism with atypical features: a classification system 4:32
Diagnosing parkinsonism with atypical features: a classification system
Oscar Gershanik • 16 Sep 2021
The current use of biomarkers in Parkinson’s disease 2:02
The current use of biomarkers in Parkinson’s disease
Brit Mollenhauer • 4 Sep 2020
Challenges hampering clinical utility of fluid biomarkers in Parkinson’s disease 1:25
Challenges hampering clinical utility of fluid biomarkers in Parkinson’s disease
Brit Mollenhauer • 4 Sep 2020
The MIND Initiative: molecular characterization in Parkinson’s disease 4:27
The MIND Initiative: molecular characterization in Parkinson’s disease
Alice Chen-Plotkin • 20 Sep 2021
Emerging biomarkers in FTD: emotional, social cognition & language deficits 2:05
Emerging biomarkers in FTD: emotional, social cognition & language deficits
Adolfo Garcia • 20 Sep 2021
The key role of genetics in the diagnosis and management of Alzheimer’s disease 1:05
The key role of genetics in the diagnosis and management of Alzheimer’s disease
Richard Pither • 21 Sep 2021
Red flags and most common secondary headaches 2:06
Red flags and most common secondary headaches
Maria-Karina Vélez-Jiménez • 14 Sep 2021
Children and adolescent headache: hormones, emergency care & guidelines 5:58
Children and adolescent headache: hormones, emergency care & guidelines
Aynur Özge • 15 Sep 2021
Assessing the performance of the modified rankin scale in stroke trials 4:41
Assessing the performance of the modified rankin scale in stroke trials
Jesse Dawson • 8 Sep 2021
Future investigation avenues in CAA 1:35
Future investigation avenues in CAA
Gargi Banerjee • 3 Sep 2021
Biofluid and genetic biomarkers for Parkinson’s disease 4:05
Biofluid and genetic biomarkers for Parkinson’s disease
Chin-Hsien Lin • 9 Sep 2021
Genetic biomarkers could aid Parkinson’s disease diagnosis and guide treatment decisions 2:00
Genetic biomarkers could aid Parkinson’s disease diagnosis and guide treatment decisions
Chin-Hsien Lin • 9 Sep 2021
The promise of CSF and PET biomarkers in CAA 2:09
The promise of CSF and PET biomarkers in CAA
Gargi Banerjee • 3 Sep 2021
Composite outcome measures may help assess recovery following stroke 2:11
Composite outcome measures may help assess recovery following stroke
Jesse Dawson • 8 Sep 2021
CSF and PET biomarkers under investigation for CAA 3:23
CSF and PET biomarkers under investigation for CAA
Gargi Banerjee • 3 Sep 2021
The content of VJNeurology is intended for healthcare professionals